Compare iShares MSCI Taiwan ETF (EWT) vs FMC Corp (FMC) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
iShares MSCI Taiwan ETF vs FMC Corp — how do they compare? iShares MSCI Taiwan ETF trades at $114.31 (market cap $12.74B), while FMC Corp trades at $8.35 (market cap $1.39B). The key difference: iShares MSCI Taiwan ETF is far larger — about 9.2× FMC Corp's market cap, and FMC Corp pays a 3.59% dividend while iShares MSCI Taiwan ETF pays none. Which is the better fit depends on your goals — on Pluang, investors hold iShares MSCI Taiwan ETF for 52 Days and FMC Corp for 68 Days on average.
| EWT | FMC | |
|---|---|---|
Market Cap | $12.74B | $1.39B |
Volume | 8,470,920 | 4,145,979 |
Sector | Broad Market / Factor | Basic Materials |
52-Week High | $118.00 | $30.63 |
52-Week Low | $60.03 | $8.35 |
Typical Hold Time | 52 Days | 68 Days |
Enterprise Value | — | $5.19B |
Dividend Yield | — | 3.59% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
EWT (iShares MSCI Taiwan ETF) trades at $113.34, down 2.49% on the day, with a bullish technical signal from moving averages despite neutral oscillators. The ETF remains heavily concentrated in Taiwan's semiconductor sector, particularly TSMC, benefiting from strong AI-driven demand. Recent news highlights Taiwan's $20 billion investment in US AI infrastructure and continued institutional interest, though geopolitical tensions with China present ongoing risks.
The outlook for EWT is positive due to Taiwan's critical role in AI semiconductor supply chains and reasonable tech valuations. Key opportunities include sustained AI demand and corporate investments, while risks center on China-Taiwan geopolitical friction and semiconductor cycle volatility. Wall Street maintains a bullish stance given growth-adjusted valuation metrics.
FMC trades at $8.92, down 1.87% on the day, with a bearish technical outlook and mixed fundamentals. The stock shows weak profitability with a net income margin of -84.83% and negative ROE of -91.47% for 2025, though recent quarterly EPS beats offer some optimism. Analyst consensus is divided with a near-even split between Buy and Hold ratings, and a $14.60 price target suggests significant upside from current levels. Recent news highlights regulatory progress for rimisoxafen in Brazil and a minority equity investment from Tessenderlo Group.
The outlook for FMC hinges on successful deleveraging and product approvals, but high debt and cyclical industry pressures pose substantial risks. While valuation ratios like P/S of 0.34 appear attractive, persistent negative margins and volatile cash flows warrant caution. The stock presents a speculative opportunity for investors betting on a turnaround, but near-term headwinds in the agricultural sector may limit upside.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About iShares MSCI Taiwan ETF
EWT tracks the MSCI Taiwan 25/50 Index, providing targeted exposure to large and mid-cap companies in Taiwan. It is heavily concentrated in the information technology sector, serving as a liquid instrument for investors seeking a single-country view of Taiwan's export-oriented and tech-driven economy.
Read more on EWT →About FMC Corp
FMC is a pure-play crop chemical company. The company has diversified its sales to create a balanced crop chemical portfolio across geographies and crop exposure. Through acquisitions, FMC is now one of the five largest patented crop chemical companies and will continue to develop new products, with a focus on biologicals, through its research and development pipeline.
Read more on FMC →
